Adaptimmune CEO and leadership

Q: Who is the CEO of Adaptimmune?

The CEO of Adaptimmune is Adrian Rawcliffe (Ad).

Q: Who is the founder of Adaptimmune?

James Julian Noble and Ian Laing founded Adaptimmune.

Zippia score 4.0

Adaptimmune CEO and executives

Executive Summary. Based on our data team's research, Adrian Rawcliffe (Ad) is the Adaptimmune's CEO. Adaptimmune has 452 employees, of which 22 are in a leadership position.

Here are further demographic highlights of the leadership team:

The Adaptimmune executive team is 36% female and 64% male.
62% of the management team is White.
14% of Adaptimmune management is Hispanic or Latino.
10% of the management team is Black or African American.

Work at Adaptimmune?

Share your experience

Rate Adaptimmune's leaders' effectiveness in guiding the company.

Name & TitleBio

Adrian Rawcliffe (Ad)

Chief Executive Officer

Adrian (Ad) Rawcliffe is a Chief Executive Officer at Adaptimmune, Senior VP:Worldwide Bus Dev at GSK, and Board Member at WaVe Life Sciences Pte Ltd and is based in Philadelphia, Pennsylvania. He has worked as Chartered Accountant at Pricewaterhouse Coopers (PwC), President/Managing Partner at Sr One, and Chief Financial Officer at Adaptimmune Therapeutics Plc. Adrian (Ad) studied at Durham University between 1990 and 1993 and Masters of Awkward.

James Julian Noble

Board Member

Ian Laing

Founder

Helena Katrina Tayton-Martin

Chief Business Officer

Helen Tayton-Martin is COO of Adaptimmune Ltd. With a PhD in molecular immunology and an MBA from London Business School, she has nearly 20 years of experience working within the Pharma, biotech and consulting environment in disciplines across preclinical and clinical development, strategic planning, due diligence and business development.Helen joined Adaptimmune from Avidex/MediGene Ltd. where she was responsible for commercial development of the soluble TCR programme in cancer and HIV therapy. Helen is responsible for all development and commercial activities, including business development and implemented Adaptimmune’s strategic partnership with GSK.

John P. Furey

Board Member

Gavin Wood

Chief Financial Officer

Gavin Wood is a Chief Financial Officer at Adaptimmune.

William C. Bertrand

Chief Operating Officer

Chief Operating Officer, General Manager and Global General Counsel, life sciences, pharmaceuticals, specialty pharmaceuticals, biotechnology. Senior enterprise executive with strong business partnership, strategic leadership, corporate development and human capital management skills. Have had responsibility at pharma and biotech companies for corporate affairs, regulatory affairs, business development, sales & marketing, finance, IT and compliance.

Elliot Norry

Chief Marketing Officer

Elliot Norry is a Senior Vice President & Chief Medical Officer at Adaptimmune.

John Lunger

Chief Patient Supply Officer

John Lunger is a Chief Patient Supply Officer at Adaptimmune.

Ali Behbahani

Board Member

Do you work at Adaptimmune?

Does the leadership team provide a clear direction for Adaptimmune?

Adaptimmune jobs

Adaptimmune founders

Name & TitleBio

James Julian Noble

Board Member

Ian Laing

Founder

Adaptimmune board members

Name & TitleBio

Adrian Rawcliffe (Ad)

Chief Executive Officer

James Julian Noble

Board Member

John P. Furey

Board Member

Ali Behbahani

Board Member

Barbara Gayle Duncan

Board Member

Charles Elliott Sigal

Board Member

Lawrence M. Alleva

Board Member

Tal Zaks

Board Member

Adaptimmune executives FAQs

Who is the CEO of Adaptimmune?

Who is the founder of Adaptimmune?

Related company executives

Working at related companies

Related company jobs

Adaptimmune highest paying jobs

Updated November 18, 2022

Zippia gives an in-depth look into the details of Adaptimmune, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Adaptimmune. The employee data is based on information from people who have self-reported their past or current employments at Adaptimmune. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Adaptimmune. The data presented on this page does not represent the view of Adaptimmune and its employees or that of Zippia.

Adaptimmune may also be known as or be related to ADAPTIMMUNE THERAPEUTICS PLC, Adaptimmune, Adaptimmune LLC, Adaptimmune Limited, Adaptimmune Ltd and Adaptimmune Therapeutics PLC.